Fitusiran
ATC Code
B02BX12
Fitusiran
Definition
A small-interfering RNA (siRNA) directed against the human glycoprotein antithrombin (AT), with potential coagulant activity. Upon subcutaneous administration of fitusiran, the siRNAs bind to AT mRNAs, which may result in the inhibition of translation of the AT protein. By preventing AT expression, the coagulation factor thrombin is increased and activated, which leads to the conversion of fibrinogen to fibrin, and thus clot formation. This reduces bleeding in hemophilia and rebalances hemostasis.
Also known as ALN 57213, ALN AT3SC, ALN-57213, ALN-AT3SC, ALN57213, ALNAT3SC, FITUSIRAN — per NCIT
Also identified as
- ATC B02BX12 per RXNORM
- NCIT NCIT:C169984 per NCIT
- UNII SV9W47ZLE1 per RXNORM